Next-Generation Serialization

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

How can stakeholders prepare for changing therapy requirements?

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Taking stock of today's gains and tomorrow's potential for generative artificial intelligence in reshaping the industry.

The parties aim to create an end-to-end digital thread that links research data all the way through to life sciences manufacturing.